Return to search

Methodological issues in randomized trials of pediatric acute diarrhea: evaluating probiotics and the need for standardized definitions and valid outcome measures

BACKGROUND: In a 2006 WHO report, diarrheal diseases ranked second among conditions afflicting children. Pediatric acute diarrhea, although most often the result of a gastrointestinal infection, can also occur as a result of antibiotic exposure. This is often referred to as antibiotic-associated diarrhea (AAD). Previous research suggests that probiotics may be effective in the treatment or prevention of various types of PAD.
METHODS: The first study involved a systematic review and meta-analysis of RCTs involving probiotics as an adjunct to antibiotics for preventing AAD in children. The second study was a systematic review of definitions and primary outcome measures employed in RCTs of PAD. The third study used a modified Delphi consensus procedure to develop a new instrument for evaluating the severity of PAD. The study involved steering committee discussions (phase 1) and two electronic surveys (phase 2 and 3) of leading experts in measurement and clinical gastroenterology.
RESULTS: The per protocol meta-analysis of ten RCTs significantly favored probiotics to prevent the incidence of diarrhea (NNT = 10). However, this effect did not withstand ITT analysis and among included trials there was considerable inconsistency regarding definitions for the reviews primary outcome measure, the incidence of diarrhea. Study two identified 121 RCTs that reported 62 unique definitions of diarrhea, 64 unique definitions of diarrhea resolution and 62 unique primary outcome measures. Thirty-one trials used grading systems to support outcome evaluation. However, none of the trials (or their citations) reported evidence of their validation. In study three experts agreed on the inclusion of five attributes containing 13 items. Attributes proposed for the IPADDS include: Diarrhea Frequency and Duration, Vomiting Frequency and Duration, Fever, Restrictions in Normal Daily Activities and Dehydration.
CONCLUSION: It is premature to draw a valid conclusion about the efficacy of probiotics for pediatric AAD. Definitions of diarrhea and primary outcome measures in RCTs of PAD are heterogeneous and lack evidence of validity. The third study represents content validity evidence for IPADDS. A numerical scoring system needs to be added and further empirical evidence of reliability and validity are required. / Experimental Medicine

Identiferoai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:AEU.10048/620
Date11 1900
CreatorsJohnston, Bradley C.
ContributorsVohra, Sunita (Department of Pediatrics & School of Public Health), Tsuyuki, Ross T. (Department of Medicine & School of Public Health), Fedorak, Richard N. (Department of Medicine), Rogers, W. Todd (Department of Educational Psychology), Huynh, Hien Q. (Department of Pediatrics), McFarland, Lynne V. (Department of Health Services Research and Development)
Source SetsLibrary and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada
LanguageEnglish
Detected LanguageEnglish
TypeThesis
Format1077427 bytes, application/pdf
RelationJohnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev: Cochrane Library 2007, Issue 2. CD004827, Johnston BC, Shamseer L, da Costa BR, Vohra S. Outcome measures in clinical trials of pediatric acute diarrhea: a systematic review. Cochrane Colloquia 2008; Oct 3-7, Freiburg, Germany (http://www.imbi.uni-freiburg.de/OJS/cca/index.php/cca/article/view/6893), Johnston BC, Supina AL, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea: A meta-analysis of placebo-controlled trials. Canadian Medical Association Journal 2006; 75(4):377-383.

Page generated in 0.0615 seconds